The Effects of Psilocybin on Social Connectedness
The study is a randomized, double-blind, placebo-controlled, expectancy-controlled, mechanistic trial. This study looks to explore whether a single dose of psilocybin (25mg) reduces amygdala reactivity to negative socioemotional stimuli during the Facial Emotion Recognition Task (FERT) compared to a placebo in adults who feel lonely or those with unresolved grief symptoms.
- Record type
- Registered clinical trial
- Status
- planned
- Phase
- Phase 1
- Institution
- Yale University
- Principal investigator
- Anahita Bassir Nia, MD
- Start date
- 2026-08-31
- End date
- 2031-12-15
- Registry ID
- NCT07693153
Listed in the DMT Code trials, studies and experiments observatory. Record type: Registered clinical trial. Only registered clinical trials carry clinical authority in this record set.